1. Halogenation at the Phenylalanine Residue of Monomethyl Auristatin F Leads to a Favorable cis/trans Equilibrium and Retained Cytotoxicity
- Author
-
Mirkka Sarparanta, Surachet Imlimthan, Iris Katariina Sokka, Filip S. Ekholm, Mikael P. Johansson, Hannu Maaheimo, Department of Chemistry, Doctoral Programme in Chemistry and Molecular Sciences, and Helsinki Institute of Sustainability Science (HELSUS)
- Subjects
LINKER ,Immunoconjugates ,Magnetic Resonance Spectroscopy ,Halogenation ,Molecular Conformation ,Pharmaceutical Science ,auristatins ,Mice ,0302 clinical medicine ,NMR-spectroscopy ,Neoplasms ,Drug Discovery ,Aminobenzoates ,Antibody-drug conjugates ,DRUG ,Cytotoxicity ,Auristatins ,0303 health sciences ,Cytotoxins ,Chemistry ,Biological activity ,Nuclear magnetic resonance spectroscopy ,Structural characterization ,Nmr-spectroscopy ,Monomethyl auristatin F ,317 Pharmacy ,030220 oncology & carcinogenesis ,Molecular Medicine ,Cancer therapeutics ,Oligopeptides ,antibody−drug conjugates ,medicine.drug ,Cell Survival ,Phenylalanine ,antibody-drug conjugates ,Antineoplastic Agents ,Article ,cancer therapeutics ,03 medical and health sciences ,Isomerism ,SDG 3 - Good Health and Well-being ,Cell Line, Tumor ,medicine ,Animals ,Humans ,VEDOTIN ,030304 developmental biology ,Combinatorial chemistry ,NMR ,structural characterization ,PET ,ANTIBODY ,DISCOVERY ,DOLASTATIN-10 ,Linker ,Cis–trans isomerism ,Conjugate - Abstract
Halogenation can be utilized for the purposes of labeling and molecular imaging, providing a means to, e.g., follow drug distribution in an organism through positron emission tomography (PET) or study the molecular recognition events unfolding by nuclear magnetic resonance (NMR) spectroscopy. For cancer therapeutics, where often highly toxic substances are employed, it is of importance to be able to track the distribution of the drugs and their metabolites in order to ensure minimal side effects. Labeling should ideally have a negligible disruptive effect on the efficacy of a given drug. Using a combination of NMR spectroscopy and cytotoxicity assays, we identify a site susceptible to halogenation in monomethyl auristatin F (MMAF), a widely used cytotoxic agent in the antibody-drug conjugate (ADC) family of cancer drugs, and study the effects of fluorination and chlorination on the physiological solution structure of the auristatins and their cytotoxicity. We find that the cytotoxicity of the parent drug is retained, while the conformational equilibrium is shifted significantly toward the biologically active trans isomer, simultaneously decreasing the concentration of the inactive and potentially disruptive cis isomer by up to 50%. Our results may serve as a base for the future assembly of a multifunctional toolkit for the assessment of linker technologies and exploring bystander effects from the warhead perspective in auristatin-derived ADCs.
- Published
- 2021
- Full Text
- View/download PDF